hit counter
ProShares Ultra Nasdaq Biotechnology (BIB) Stock News Sentiment & Price - Sentifly
BIB - Sentifly



Your watchlist is empty. Go add some tickers to it!

ProShares Ultra Nasdaq Biotechnology (BIB)

Exchange Traded Fund
BIB Price and Sentiment
Positive, Negative
Loading chart...
BIB Latest news
Zacks Investment Research
Take a Look at the Top-Performing Biotech ETFs YTD
2021-10-02 09:25

The pandemic has triggered a race to introduce vaccines and treatment options, opening up investment opportunities in the biotech sector.

ETF Trends
Could Biotech ETFs Get Another Boost From JNJ News?
2021-08-26 17:08

This has been a pivotal week for biotech news, as Johnson & Johnson said Wednesday that a booster shot of its COVID-19 vaccine generated a promising immune response in early stage clinical trials. This follows the Monday news that the FDA fully approved the Pfizer and BioNTech COVID-19 vaccine, making it the first vaccine in the U.S. [.

Zacks Investment Research
Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs
2021-08-26 12:14

Investors could easily tap the bullish trend by considering a near-term long on the biotech sector.

ETF Trends
Pfizer-BioNTech COVID-19 Vaccine Garners Full FDA Approval
2021-08-24 13:10

The FDA has officially given full approval to Pfizer and BioNTech for their COVID-19 vaccine, potentially making way for more approvals and more vaccine mandates, reports CNBC. It is a move that officials are hoping will encourage those who have been reluctant to receive a vaccine to get vaccinated.

ETF Trends
Biotech ETFs Are Already Benefitting from Pfizer Vaccine's Full Approval
2021-08-23 15:06

There could be big gains ahead for biotech ETFs, as the Food and Drug Administration on Monday fully approved the Pfizer and BioNTech coronavirus vaccine, making it the first vaccine in the U.S. to be awarded such a designation. The move could generate additional confidence for more businesses, schools, and universities to embrace the current vaccine mandates.

ETF Trends
As Covid Cases Mutate, the Biotech Industry Works to Keep Up
2021-07-20 13:15

As the Delta variant sweeps across the globe, pharmaceutical and biotech companies are working to ensure vaccines continue to cover the population, as well as working on booster doses that can adapt to future mutations.  “Delta has gone the way we were hoping it wouldn't.

Zacks Investment Research
5 Best Leveraged ETFs of Last Week
2021-06-14 09:47

We highlight a few leveraged ETF areas that won last week.

Zacks Investment Research
Top-Performing Biotechnology ETFs Amid Coronavirus Outbreak
2020-07-13 16:56

From vaccine-related progress to development of cell therapies for the treatment of coronavirus, all kept the rally in the biotech sector alive.

Zacks Investment Research
4 Best-Performing Leveraged ETF Areas of Last Week
2020-06-22 13:00

Last week witnessed a tug-of-war between bulls and bears.